| Literature DB >> 2194539 |
Abstract
Current status of endocrine treatment for breast cancer is reviewed. Several new aromatase inhibitors as well as antiestrogens are being introduced for clinical trials. As different drugs within the same drug group may possess different biochemical actions, apart from being useful drugs for treatment of breast cancer, these drugs may also extend our knowledge about the endocrinology of breast cancer.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2194539 DOI: 10.3109/02841869009090018
Source DB: PubMed Journal: Acta Oncol ISSN: 0284-186X Impact factor: 4.089